CTTACC 2019

Cellular Therapies and Transfusion Medicine in Trauma and Critical Care – Looking Towards the Future

 

DECEMBER 11-13  |  SAN DIEGO

Presented by the University of California San Francisco Department of Laboratory Medicine
This is the fourth in a series of conferences entitled “Cellular Therapies and Transfusion Medicine in Trauma and Critical Care Medicine.”  It is our belief that cellular therapies, adjuncts in resuscitation and novel blood products represent critical areas in transfusion medicine that have the potential to dramatically improve outcomes in trauma patients. Previous conferences have resulted in multiple cross disciplinary collaborations and grants for pre-clinical studies and clinical trials.

The goal of this meeting is to bring together the expertise and input of blood bankers, clinicians, basic scientists, industry, FDA, NIH, AABB, and DoD representatives to discuss existing barriers in the translation of these novel therapies in trauma and critical care, fields with limited new therapeutic options and unlimited opportunities for advancement. Our speakers are leaders in their fields and have diverse expertise and knowledge in these areas. Our target audience includes clinicians, physician-scientists, basic scientists and industry leaders who are interested in the field, currently working in or anticipate working in the field of novel therapeutics for critically ill patients. Topics that will be covered include cellular therapies and novel products in spinal cord injury (SCI), traumatic brain injury (TBI), hemorrhagic shock, bone and wound healing, ARDS, AKI and stroke. Areas in novel blood products will include the latest ground breaking research in plasma, RBC and platelet based resuscitation in trauma, pathogen reduction, dried platelets, dried plasma, whole blood, cold stored platelets. Discussion groups will be focused on barriers in translation of novel products in trauma which include clinical trial design, funding, cell and novel product sourcing and production. Regulatory insight will be included from the FDA. We invite your organization to participate as a sponsor. We have limited space available for table displays during the event. Other sponsorship opportunities are available. Please note that industry attendance to this conference is restricted to sponsorship only.

2 ½ DAY CONFERENCE

Transfusion Medicine in Trauma and Critical Care

 
R

Cellular Therapies in Trauma and Critical Care Medicine

 
l

Barriers in Translation for Cellular Therapies in Trauma and Critical Care